Related Experiment Videos
Ethambutol-induced thrombocytopaenia.
1K.G.'s Medical College, Lucknow, India.
Tubercle
|September 1, 1989
Summary
A rare case of ethambutol-induced thrombocytopenia is reported. This chemotherapy adverse effect caused widespread purpura in a patient within six days of treatment initiation.
Area of Science:
- Pharmacology
- Hematology
- Oncology
Background:
- Ethambutol is a first-line antituberculosis drug.
- Thrombocytopenia is a potential, though rare, adverse effect of various medications.
- Drug-induced thrombocytopenia can lead to serious bleeding complications.
Observation:
- A patient receiving ethambutol chemotherapy developed a sudden onset of widespread purpura.
- The purpura appeared six days after initiating ethambutol treatment.
Findings:
- The case highlights a rare instance of ethambutol-induced thrombocytopenia.
- The rapid onset of purpura suggests a direct or immune-mediated drug effect.
Implications:
- Clinicians should be vigilant for thrombocytopenia in patients treated with ethambutol.
- Early recognition and management of drug-induced thrombocytopenia are crucial for patient outcomes.
- This case contributes to the understanding of rare adverse drug reactions in chemotherapy regimens.